RPL presents further confirmation of the food effect on the QTc interval

Posted:
30
November 2012

Food produces a typical pattern QTcF shortening which is predictable, reproducible and can be demonstrated even in small populations of around 10 volunteers.Further to our publication �Shortening of the QT Interval After Food Can Be Used to Demonstrate Assay Sensitivity in Thorough QT Studies� published October 2012 in the Journal of Clinical Pharmacology, it is proposed that food effects on ECG demonstrated in SAD and MAD studies can be used to show assay sensitivity thereby enhancing the value of the ECG assessment in these studies significantly.Richmond Pharmacology will present on this topic at the 33rd Annual Meeting of The Japanese Society of Clinical Pharmacology and Therapeutics, taking place this year in Okinawa from 29 Nov to 1 Dec. The presentation will be held on Day 2, from 14h30-15h50 (Room 4 - Conference Hall B3+4).View programContact us to arrange a face-to-face meeting

Latest news

Upcoming Event

On Helix, Transforming new medicine discovery

13-14 July 2020
Richmond Pharmacology will be showcasing a presentation on Adaptive Early Phase Clinical Trials as part of the ON HELIX digital event.
View event

COVID-19 – External Monitoring Guidelines

July 1, 2020
Richmond Pharmacology is constantly assessing health and safety risks posed by COVID-19 and is regularly reviewing Public Health England guidance.
Read more

First transdermal patch to treat schizophrenia hits market

March 18, 2020
The US Food and Drug Administration (FDA) has officially approved a transdermal patch to treat schizophrenia developed by Hisamitsu Pharmaceutical Co following successful
Read more

Statement: COVID-19

March 23, 2020
Richmond Pharmacology are continuously risk-assessing our activity in relation to the COVID-19 crisis and we are evaluating what activity can continue, what precautions need to be put in place and what needs to be suspended.
Read more